Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05868070
Other study ID # 0720234107
Secondary ID 202013C18
Status Recruiting
Phase N/A
First received
Last updated
Start date July 10, 2023
Est. completion date December 2024

Study information

Verified date January 2024
Source Seoul National University Hospital
Contact Woo Hyung Lee, MD, PhD
Phone 82-10-4640-6283
Email whlee909@snu.ac.kr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Intensive care unit (ICU)-acquired weakness (ICU-AW) is one of the most common complications of post-ICU syndrome. It is the leading cause of gait disturbance, decreased activities of daily living, and poor health-related quality of life. The early rehabilitation of critically ill patients can reduce the ICU-AW. We designed a protocol to investigate the feasibility and safety of conventional rehabilitation with additional in-bed cycling/stepping in critically ill patients. The study is designed as a single-center, open-label, pilot, randomized, parallel-group study. After the screening, participants are randomly allocated to two groups, stratified by mechanical ventilation status. The intervention group will be provided with exercises of in-bed cycling/stepping according to the level of consciousness, motor power, and function in addition to conventional rehabilitation. In contrast, the control group will be provided with only conventional rehabilitation. The length of the intervention is from ICU admission to discharge, and interventions will be conducted for 20 minutes, a maximum of three times per session. The primary outcome is the number and percentage of completed in-bed cycling/stepping sessions, the duration and percentage of in-bed cycling/stepping sessions, and the number of cessations of in-bed cycling/stepping sessions. The secondary outcomes are the interval from ICU admission to the first session of in-bed cycling/stepping, the number and percentage of completed conventional rehabilitation sessions, the duration and percentage of conventional rehabilitation sessions, the number of cessations of conventional rehabilitation sessions, the number of adverse events, level of consciousness, functional mobility, muscle strength, activities of daily living, and quality of life. This study is a pilot clinical trial to investigate the feasibility and safety of conventional rehabilitation with additional in-bed cycling/stepping in critically ill patients. If the expected results are achieved in this study, the methods of ICU rehabilitation will be enriched.


Recruitment information / eligibility

Status Recruiting
Enrollment 24
Est. completion date December 2024
Est. primary completion date December 2024
Accepts healthy volunteers No
Gender All
Age group 45 Years and older
Eligibility Inclusion Criteria: - Age = 45 - Admission to ICU = 72 hours - Patient deemed to need = 48 hours of ICU care - Premorbid functional ambulation category= 2 Exclusion Criteria: - Neurologic disorders i.Central nervous system: acute stroke, advanced dementia, hypoxic-ischemic encephalopathy ii. Peripheral nervous system: amyotrophic lateral sclerosis, myasthenia gravis, acute inflammatory demyelinating polyneuropathy - Acute deep venous thrombosis, pulmonary embolism - Pneumothorax - External fixator, superficial metallic implants, amputation, eschar, etc - Expected ICU discharge within 3 days of admission - Pregnant - Difficulty in obtaining consent (rejection, no family, if the family does not agree) - If the life expectancy is less than 6 months

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Conventional rehabilitation plus multimodal exercise
Depending on the patient's condition, the intervention gradually progressed to passive, active assistive, active, and resistive exercise modes and the frequency of exercise interventions is gradually increased, and the application time of cycling/stepping is 20 minutes per session, and up to 3 times if there is no serious problem corresponding to the safety standards.

Locations

Country Name City State
Korea, Republic of Seoul National University Hospital Seoul Jongno-gu

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary the number and percentage of completed in-bed cycling/stepping sessions the number and percentage of completed in-bed cycling/stepping sessions at every intervention (from baseline to ICU discharge, an average of 3 weeks)
Primary the duration and percentage of in-bed cycling/stepping sessions the duration and percentage of in-bed cycling/stepping sessions at every intervention (from baseline to ICU discharge, an average of 3 weeks)
Primary the number of cessations of in-bed cycling/stepping sessions the number of cessations of in-bed cycling/stepping sessions at every intervention (from baseline to ICU discharge, an average of 3 weeks)
Secondary the interval from ICU admission to the first session of in-bed cycling/stepping the interval from ICU admission to the first session of in-bed cycling/stepping at every intervention (from baseline to ICU discharge, an average of 3 weeks)
Secondary the number and percentage of completed conventional rehabilitation sessions the number and percentage of completed conventional rehabilitation sessions at every intervention (from baseline to hospital discharge, an average of 2 months)
Secondary the duration and percentage of conventional rehabilitation sessions a 5-item to measure physical function for patients in ICU and consists of 5 the duration and percentage of conventional rehabilitation sessions at every intervention (from baseline to hospital discharge, an average of 2 months)
Secondary the number of cessations of conventional rehabilitation sessions the number of cessations of conventional rehabilitation sessions at every intervention (from baseline to hospital discharge, an average of 2 months)
Secondary the number of adverse events the number of adverse events at every intervention (from baseline to hospital discharge, an average of 2 months)
Secondary the confusion assessment method for the ICU (CAM-ICU) The CAM-ICU is a short test for the diagnosis of delirium in adult patients in critical care settings. As a tool to evaluate the presence of delirium, it is evaluated by four characteristics. Trait 1 is characterized by acute changes in mental state or fluctuating mental state, trait 2 is characterized by attention deficit, trait 3 is characterized by unsystematic thinking, and trait 4 is characterized by changes in the level of consciousness. The presence of delirium is when the trait 1 and trait 2 are present, and trait 3 or trait 4 is present. baseline-ICU discharge (an average of 3 weeks)
Secondary Richmond agitation-sedation scale (RASS) RASS is a valid and reliable assessment tool to measure the level of alertness and agitated behaviour in critically-ill patients. baseline-ICU discharge (an average of 3 weeks)
Secondary Functional ambulation category (FAC) FAC is a 6-point functional gait test that assesses walking ability to determine how much support a patient needs when walking, with or without a personal assistive device. Nonfunctional gait is scored as 0, level 2 dependent gait is scored as 1, Level 1 dependent gait is scored as 2, supervised independent gait is scored as 3, independent gait on a flat surface is scored as 4, and independent gait anywhere is scored as 5. baseline
Secondary Functional status score (FSS-ICU) a 5-item to measure physical function for patients in ICU and consists of 5 categories: rolling, supine-to-sit transfers, unsupported sitting, sit-to-stand transfers, and ambulation. Each category was rated from 0 to 7, with a maximum cumulative score of 35. baseline-ICU discharge (an average of 3 weeks)
Secondary Short physical performance battery score (SPPB) SPPB is a common well-established measurement of physical performance and involves a timed 4-m walk, timed repeated chair sit-to-stand test, and 10-s balance tests including side-by-side, semi-tandem, and full-tandem. Each of the three subtests of the SPPB is scored from 0 to 4, and summed for a total score ranging from 0 to 12. ICU discharge (an average of 3 weeks)-hospital discharge (an average of 2 months)-1 month after the hospital discharge (an average of 3 months)-3 months after the hospital discharge (an average of 5 months)
Secondary de Morton Mobility Index (DEMMI) DEMMI is a 15 item measure of mobility. In bed, three items will be evaluated: bridge, roll onto side, and lying to sitting. In the chair, three items will be evaluated: sit unsupported in chair, sit to stand from chair, and sit to stand without using arms. In the static balance, four items will be evaluated: stand unsupported, stand feet together, stand on toes, and tandem stand with eyes closed. And walking will be evaluated two items: walking distance and walking independence. In the dynamic balance, three items are evaluated pick up pen from floor, walks 4 steps backwards, jump. The DEMMI is considered an important characteristic of independent mobility and includes items that have validity in measuring the mobility domain defined by the World Health Organization. Using a simple conversion table for 15 evaluation items, it can convert ordinal mobility score (out of 19) into interval mobility score (out of 100). baseline-ICU discharge (an average of 3 weeks)-hospital discharge (an average of 2 months)-1 month after the hospital discharge (an average of 3 months)
Secondary Falls efficacy scale (FES) The FES is a questionnaire that evaluates the fear of falls in daily life at home and is a 16 item questionnaire with a score ranging from minimum 16 to maximum 64. hospital discharge (an average of 2 months)-1 month after the hospital discharge (an average of 3 months)-3 months after the hospital discharge (an average of 5 months)
Secondary Activities-specific balance confidence scale (ABC) ABC scale is a valid and reliable instrument to self-reporting measure of evaluates the fear of falling not only inside the house but also outside the house . hospital discharge (an average of 2 months)-1 month after the hospital discharge (an average of 3 months)-3 months after the hospital discharge (an average of 5 months)
Secondary Sum of medical research council (MRC) MRC-sum score is a commonly used for evaluating the strength of the upper and lower extremities from grade 5 to 0. The sum of MRC scores will be evaluated the strength of a total of 12 joints of 6 joints including the arms, elbow, wrist, hip, knee, and ankle on both sides is measured, for a total of 60 points. baseline-ICU discharge (an average of 3 weeks)-hospital discharge (an average of 2 months)-1 month after the hospital discharge (an average of 3 months)
Secondary Hand grip strength (HGS) HGS is commonly performed to measure hand muscle power using a dynamometer and provide an objective index of the functional integrity of the upper extremity. baseline-ICU discharge (an average of 3 weeks)-hospital discharge (an average of 2 months)-1 month after the hospital discharge (an average of 3 months)
Secondary Modified barthel index (MBI) The MBI is a measure of activities of daily living and involves 10 domains of activities including bowel control, bladder control, as well as help with grooming, toilet use, feeding, transfers, walking, dressing, climbing stairs, and bathing. ICU discharge (an average of 3 weeks)-hospital discharge (an average of 2 months)-1 month after the hospital discharge (an average of 3 months)
Secondary 36-Item Short Form Survey (SF-36) version 2.0. SF-36 is a well-researched, self-reported measure of functional health. Each item consists of physical functioning, role limitations physical, bodily pain, general medical health, vitality, social functioning, role limitations emotional, mental health, physical component scale, and mental component scale. hospital discharge (an average of 2 months)-1 month after the hospital discharge (an average of 3 months)-3 months after the hospital discharge (an average of 5 months)
Secondary days to initiate ambulation (FAC =2) days to initiate ambulation (FAC =2) at every intervention (from baseline to hospital discharge, an average of 2 months)
Secondary mortality-28 days mortality-28 days at every intervention (from baseline to hospital discharge, an average of 2 months)
Secondary duration of mechanical ventilation duration of mechanical ventilation at every intervention (from baseline to ICU discharge, an average of 3 weeks)
Secondary length of stay in the ICU length of stay in the ICU at every intervention (from baseline to ICU discharge, an average of 3 weeks)
Secondary length of stay in the hospital length of stay in the hospital at every intervention (from baseline to hospital discharge, an average of 2 months)
Secondary Pittsburgh rehabilitation participation scale (PRPS) PRPS is a clinician-rated instrument designed to assess a patient's participation in therapy. It is evaluated on a scale of 1 to 6 as an evaluation of the patient's effort and activeness participating in treatment. at every intervention (from baseline to ICU discharge, an average of 3 weeks)
Secondary concomitant occupational therapy and its application dose concomitant occupational therapy and its application dose at every intervention (from baseline to hospital discharge, an average of 2 months)
Secondary concomitant pulmonary rehabilitation and its application dose concomitant pulmonary rehabilitation and its application dose. at every intervention (from baseline to hospital discharge, an average of 2 months)
See also
  Status Clinical Trial Phase
Completed NCT01885442 - TryCYCLE: A Pilot Study of Early In-bed Leg Cycle Ergometry in Mechanically Ventilated Patients N/A
Completed NCT05303623 - The Effect of Inspiratory Muscle Training on Diaphragmatic Function in Mechanically Ventilated Patients N/A
Recruiting NCT04541602 - Detection of Neuromuscular Complications in Critically Ill Patients
Completed NCT05297188 - The Effect of Ergonomic Sleep Mask Usage on Patients' Sleep Quality and Comfort
Completed NCT04589910 - Measuring Thickness of the Normal Diaphragm in Children Via Ultrasound. N/A
Completed NCT04833621 - Is NMES Treatment in Sepsis/ Septic Shock Patients Protective in Development of ICU-AW? N/A
Active, not recruiting NCT03471247 - CYCLE: A Randomized Clinical Trial of Early In-bed Cycling for Mechanically Ventilated Patients N/A
Completed NCT05282576 - Effect of Neurophysiological Facilitation Techniques in Intensive Care Patients N/A
Completed NCT04633421 - PRotEin Provision in Critical IllneSs N/A
Completed NCT02391103 - Effects of Neuromuscular Electrical Stimulation on Muscle Mass and Strength in Critically Ill Patients After Cardiothoracic Surgery N/A
Completed NCT04154995 - Intensive Care Unit Recovery
Not yet recruiting NCT06409611 - MUSCLE EFFECTS OF NEUROMUSCULAR ELECTROSTIMULATION IN MECHANICALLY VENTILATED PATIENTS IN AN ICU N/A
Completed NCT06440265 - Validity and Reliability of Korean Version of AM-PAC Inpatient Short Form (Low Function) in Critically Ill Patients
Completed NCT02377830 - CYCLE Pilot Randomized Trial Phase 2
Completed NCT04435080 - Physical Rehabilitation in ICU in ARDS Patients With COVID-19
Terminated NCT04332263 - Neuromuscular Electrical Stimulation in ICU Patients N/A
Terminated NCT05474157 - Sarcopenia and Related Factors in Coronavirus Disease 2019 (COVID-19) Following Intensive Care
Not yet recruiting NCT06442254 - The Effects of Virtual Reality in Intensive Care Patients N/A
Completed NCT04459533 - Sparing in Neuromuscular Blockade in COVID 19 ICU
Completed NCT05591248 - Virtual Reality Rehabilitation on the Intensive Care Unit for Critically Ill Patients N/A